Benchmark Capital Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Benchmark Capital Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$398,000
-38.4%
3,650
-8.8%
0.40%
-18.5%
Q3 2018$646,000
+144.7%
4,000
+100.0%
0.49%
+143.0%
Q2 2018$264,000
-79.3%
2,000
-88.4%
0.20%
-80.2%
Q1 2018$1,278,000
+8.1%
17,250
-18.8%
1.01%
+9.5%
Q4 2017$1,182,000
+27.8%
21,250
+4.2%
0.92%
+28.4%
Q3 2017$925,000
+174.5%
20,400
+104.0%
0.72%
+169.9%
Q2 2017$337,000
+51.8%
10,000
+33.3%
0.27%
+52.0%
Q1 2017$222,000
+7.8%
7,5000.0%0.18%
+2.3%
Q4 2016$206,000
-32.9%
7,500
+50.0%
0.17%
-26.3%
Q3 2016$307,000
-74.1%
5,000
-92.0%
0.23%
-76.0%
Q2 2016$1,185,000
-12.5%
62,150
-10.4%
0.97%
-18.7%
Q1 2016$1,354,000
-32.2%
69,350
+34.0%
1.19%
-29.7%
Q4 2015$1,997,000
+18.4%
51,750
-1.5%
1.69%
+22.9%
Q3 2015$1,687,000
-37.2%
52,550
-40.5%
1.38%
-27.2%
Q2 2015$2,688,000
+121.1%
88,350
-3.5%
1.89%
+136.1%
Q1 2015$1,216,000
-8.9%
91,550
-0.8%
0.80%
-10.8%
Q4 2014$1,335,000
-41.7%
92,250
-15.0%
0.90%
+12.5%
Q3 2014$2,290,000
+120.2%
108,500
+210.9%
0.80%
+22.4%
Q2 2014$1,040,000
+24.0%
34,9000.0%0.65%
+11.7%
Q1 2014$839,000
-4.0%
34,900
-18.6%
0.58%
-3.8%
Q4 2013$874,000
-14.6%
42,900
+98.2%
0.61%
-17.4%
Q3 2013$1,023,000
+21.9%
21,650
-1.8%
0.73%
+13.4%
Q2 2013$839,00022,0500.65%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders